✦ LIBER ✦

PA.147 PROLONGED SCHEDULED THERAPY WITH INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: EVALUATION OF CLINICAL REMISSION AND MUCOSAL HEALING

✍ Scribed by L. Grossi; M. Spezzaferro; L.F. Sacco; M.E. Serio; M. Amitrano; B. Cerasa; L. Marzio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Majority of patients with inflammatory b

✍ Judith E. Baars; Veerle J.A.A. Nuij; Bas Oldenburg; Ernst J. Kuipers; Christien 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

P302 The impact of induction and mainten

✍ J. Kierkus; E. Szymanska; M. Dadalski; A. Wegner; G. Oracz; M. Gorczewska; S. Sz 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

W1222 Intestinal Mucosal Expression of M

✍ Arijs, Ingrid; Quintens, Roel; Lemaire, Katleen; Van Lommel, Leentje; Van Steen, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Addition of an Immunomodulator to Inflix

✍ Ben–Horin, Shomron; Waterman, Matti; Kopylov, Uri; Yavzori, Miri; Picard, Orit; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Clinical Value of Measuring Trough Level

✍ Pariente, Benjamin ;Pineton de Chambrun, Guillaume ;Desroches, Marine ;De Cassan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Clinical Correlates of Infliximab (IFX)

✍ Felipez, Lina M. ;Gokhale, Ranjana ;Wroblewski, Kristen ;Godick, Anna ;Kirschner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 95 KB